Gastric DiseaseNCT03267355
Indications and Outcomes of Endoscopic Ultrasound in Tanta
A study testing Endoscopic Ultrasound in people with Gastric Disease and Intestinal Disease, run by Tanta University at 1 site in Egypt.
Trial summary
The aim is to evaluate the initial experience for the indications and outcomes of EUS in Tanta university hospital. Read more about this study
- Who is it for?
- Any age
- Conditions the study is for
- Gastric Disease, Intestinal Disease, Pancreatic Diseases
- What is being tested?
- Endoscopic Ultrasound
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteEgypt
- Study dates
- Jan 2016to Dec 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages Any age
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Who may be able to join
- All cases of gastrointestinal EUS
Who cannot join
- Missed data
Trial locations and contacts
1 site in 1 country.
Egypt1 site, 1 recruiting
- Recruiting
Tanta university hospital
Cairo
Sherief Abd-Elsalam, 00201000040794, Sherif_tropical@yahoo.com
About this study
Official title: Indications and Outcomes of Gastrointestinal Endoscopic Ultrasound in Tanta-Egypt: Initial Experience.
The aim is to evaluate the initial experience for the indications and outcomes of EUS in Tanta university hospital.
Read the detailed description
Detection of main causes for referral to EUS in Tanta, Egypt.
- Being tested
- Endoscopic Ultrasound
- Medical subject headings
- Stomach Diseases, Intestinal Diseases, Pancreatic Diseases, Esophageal Diseases
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Endoscopic UltrasoundDevice
Also called EUS
Indication of EUS
| Study group | Role | What they receive |
|---|---|---|
| Gastrointestinal diseases | Experimental | Endoscopic Ultrasound Receives: Device: Endoscopic Ultrasound |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of different indications for Endoscopic Ultrasound in Tanta, Egypt
Evaluation of the initial experience of the indications and outcomes of GIT EUS
Measured: 10 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted30 Aug 2017
- Study startJan 2016
- Primary completionJan 2019 (estimated)
- Study completionDec 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Gastric DiseaseStudies of the same condition, open and under way.
- More trials run by Tanta UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Tanta University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Asem Elfert, Professor, Principal investigator, Tanta University Faculty of MedicineFerial El-kalla, Professor, Principal investigator, Tanta university Faculty of MedicineSamah Mosaad, consultant, Study director, Tanta University Faculty of MedicineWalaa Elkhalawany, Consultant, Study director, Tanta University Faculty of MedicineReham Elkhouly, Consultant, Study chair, Tanta University Faculty of MedicineEslam Saber, Specialist, Study chair, Tanta University Faculty of medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03267355
- Sponsor's protocol ID
- EUS TANTA
- Status last verified
- Aug 2017
- First submitted
- 27 Aug 2017
- Last updated
- 30 Aug 2017
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 30 Aug 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Indications and Outcomes of Gastrointestinal Endoscopic Ultrasound in Tanta-Egypt: Initial Experience.
- ClinicalTrials.gov ID
- NCT03267355
- Acronym / sponsor ID
- EUS TANTA
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Tanta UniversityUniversity, hospital or other
- Study start
- Jan 2016 (actual)
- Primary completion
- Jan 2019 (estimated)
- Study completion
- Dec 2019 (estimated)
- First posted
- 30 Aug 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim is to evaluate the initial experience for the indications and outcomes of EUS in Tanta university hospital.
Detailed description
Detection of main causes for referral to EUS in Tanta, Egypt.
Study design
- Primary purpose
- Health services research
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Gastrointestinal diseases | Experimental | Device: Endoscopic UltrasoundEndoscopic Ultrasound |
Who may qualify
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
Key inclusion criteria (1 listed)
- All cases of gastrointestinal EUS
Key exclusion criteria (1 listed)
- Missed data
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Endoscopic UltrasoundAlso: EUSIndication of EUS | Device | Gastrointestinal diseases |
Primary outcome
Number of different indications for Endoscopic Ultrasound in Tanta, Egypt
Time frame: 10 months
Evaluation of the initial experience of the indications and outcomes of GIT EUS
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Aug 2017.
- Individual participant dataSharing planned: Undecided
Related trials for Gastric Disease
RecruitingPhase 1/2
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Solid Tumor, Non-Small Cell Lung Cancer
RecruitingPhase 2/3
Multicenter Validation Trial of [18F]AlF-FAPI-74 for PET Imaging of Cancer-associated Fibroblasts Through Fibroblast Activation Protein Inhibitors (FAPI) in Different Tumor Types
Oesophageal Cancer, Gastric Cancer
Active, not recruitingPhase 3
Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer
Peptic Ulcer
Not yet recruitingPhase 1
GK01 Cell Therapy in Gastric Cancer With Peritoneal Metastasis
Gastric Cancer (GC)
RecruitingPhase 2
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
Overweight or Obesity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Asem Elfert, Professor principal investigator
Tanta University Faculty of Medicine
Ferial El-kalla, Professor principal investigator
Tanta university Faculty of Medicine
Samah Mosaad, consultant study director
Tanta University Faculty of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Endoscopic Ultrasound in people with Gastric Disease and Intestinal Disease, run by Tanta University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 30 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Sherief Abd-Elsalam, Ph D (00201095159522, Sheriefabdelsalam@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of different indications for Endoscopic Ultrasound in Tanta, Egypt (time frame: 10 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Aug 2017; AzTrials last refreshed its copy on 8 Nov 2026.